La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

AcouSort Bilan de santé

Santé financière contrôle des critères 4/6

AcouSort possède un total de capitaux propres de SEK20.0M et une dette totale de SEK0.0, ce qui porte son ratio d'endettement à 0%. Son actif total et son passif total sont SEK28.1M et de SEK8.1M.

Informations clés

Ratio d'endettement

SEK 0

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	SEK 20.38m
Fonds propres	SEK 19.98m
Total du passif	SEK 8.09m
Total des actifs	SEK 28.07m

Mises à jour récentes de la santé financière

Recent updates

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

Aug 15

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Nov 25

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Aug 09

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Mar 02

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

May 03

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Jan 18

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de ACOU ( SEK24.1M ) dépassent ses passifs à court terme ( SEK8.1M ).

Passif à long terme: Les actifs à court terme de ACOU ( SEK24.1M ) ne couvrent pas ses passifs à long terme ( SEK-1,000.0 ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: ACOU est sans dette.

Réduire la dette: ACOU n'a eu aucune dette au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: ACOU dispose d'une piste de trésorerie suffisante pour plus d'un an sur la base de son flux de trésorerie disponible actuel.

Prévisions de trésorerie: ACOU dispose de moins d'un an de marge de trésorerie si le flux de trésorerie disponible continue de diminuer à un taux historique de 14.4 % chaque année

AcouSort Bilan de santé

Santé financière contrôle des critères 4/6

Informations clés

Mises à jour récentes de la santé financière

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Recent updates

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) to Report Q3, 2024 Results on Nov 27, 2024

New minor risk - Shareholder dilution

AcouSort AB (publ) has completed a Composite Units Offering.

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.32 loss in 3Q 2022)

New major risk - Share price stability

AcouSort AB (publ) to Report Q4, 2023 Results on Feb 28, 2024

New major risk - Financial position

New minor risk - Share price stability

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

First quarter 2023 earnings released: kr0.23 loss per share (vs kr0.20 loss in 1Q 2022)

AcouSort AB (publ) Launches Next Generation AcouTrap at CYTO 2023

Full year 2022 earnings released: kr0.98 loss per share (vs kr0.92 loss in FY 2021)

Founder & Independent Director recently bought kr68k worth of stock

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Third quarter 2022 earnings released: kr0.32 loss per share (vs kr0.30 loss in 3Q 2021)

Second quarter 2022 earnings released: kr0.31 loss per share (vs kr0.31 loss in 2Q 2021)

The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics

AcouSort AB Announces Executive Appointments

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

AcouSort AB (publ) and Werfen's Joint Patent Application Has Received National Approval in US

AcouSort AB (publ) Announces Scientific Progress with AcouWash Enables New Method for Cancer Treatment Monitoring

First quarter 2022 earnings released: kr0.20 loss per share (vs kr0.15 loss in 1Q 2021)

Founder & Independent Director recently bought kr95k worth of stock

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort will launch AcouWash 2 at international conference

Second quarter 2021 earnings released: kr0.31 loss per share (vs kr0.12 loss in 2Q 2020)

AcouSort AB (publ) Announces Development Process of AcouPlasma Optical Reaches Important Milestone

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.10 loss in 1Q 2020)

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

Acousort Strengthens Commercial Offering with the Release of New Acouwash Application Notes

Full year 2020 earnings released: kr0.70 loss per share (vs kr0.96 loss in FY 2019)

AcouSort AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

AcouSort AB (publ) to Report Q3, 2021 Results on Nov 24, 2021

AcouSort AB Enters Collaboration Agreement with Belgian Diagnostics Company

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Physio-Tech Co.,Ltd. acquired AcouTrap system from AcouSort AB (publ) (OM:ACOU).

New 90-day high: kr26.90

New 90-day high: kr22.30

New 90-day high: kr21.80

Third quarter 2020 earnings released: kr0.20 loss per share

New 90-day high: kr19.25

New 90-day high: kr16.85

New 90-day high: kr12.40

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines